TFCP2 Genetic Polymorphism Is Associated with Predisposition to and Transplant Prognosis of Hepatocellular Carcinoma
Table 1
Clinical data for the non-HCC and HCC groups.
Variable
Non-HCC ()
HCC ()
value
Age (years), n (%)
0.155
≤50
128 (64)
66 (56)
>50
72 (36)
53 (44)
Gender
0.008
Male, n (%)
163 (82)
110 (92)
Female, n (%)
37 (19)
9 (8)
BMI (kg/m2)
23.2 ± 6.4
24.2 ± 8.5
0.299
Etiology of liver diseases, n (%)
0.164
HBV
151 (76)
98 (82)
Others
49 (24)
21 (18)
Child score
9.5 ± 2.1
7.5 ± 2.1
<0.001
MELD score
21.2 ± 11.8
12.1 ± 5.7
<0.001
BMI, body mass index; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; MELD, model for end-stage liver disease. The data were presented as mean ± SD. Values in italics indicate significance.